BIGG Rec Logo
BIGG Rec Logo
New Evidence Available

Updated Recommendation

A new evidence synthesis was published:2023, Mental Health Gap Action Programme (‎mhGAP)‎ guideline for mental, neurological and substance use disorders, [‎3rd ed.]‎.

View latest version (2023)

Bibliographic Info

GuidelineUpdate of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological and substance use disorders, 2015
Year of Publication2015
Issuing InstitutionWorld Health Organization

Recommendation

Status
Retired

Recommended in favor

Conditional

Treatment for moderate-severe depressive disorder . As first-line therapy, health care providers may select psychological treatments (such as behavioural activation [BA], cognitive behavioural therapy [CBT], or interpersonal psychotherapy [IPT]) or antidepressant medication (such as selective serotonin reuptake inhibitors [SSRIs] and tricyclic antidepressants [TCAs]). They should keep in mind the possible adverse effects associated with antidepressant medications, the ability to deliver either intervention (in terms of expertise, and/or treatment availability), and individual preferences.

Powered byEpistemonikos Foundation